Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 12-2012 | 06-2012 | 12-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | -6,970 | 0 | -2,560 | 0 |
| Depreciation Amortization | 0 | 4,750 | 0 | 4,330 | 0 |
| Other Working Capital | 0 | 150 | 0 | -2,720 | 0 |
| Other Operating Activity | 0 | 31,070 | 0 | 20,680 | 0 |
| Operating Cash Flow | $0 | $29,000 | $0 | $19,730 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -790 | 0 | -3,850 | 0 |
| Net Acquisitions | 0 | 9,820 | 0 | 0 | 0 |
| Other Investing Activity | 0 | -320 | 0 | 0 | 0 |
| Investing Cash Flow | $0 | $8,710 | $0 | $-3,850 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -35,660 | 0 | -38,180 | 0 |
| Financing Cash Flow | $0 | $-35,660 | $0 | $-38,180 | $0 |
| Exchange Rate Effect | 0 | -150 | 0 | 320 | 0 |
| Beginning Cash Position | 0 | 24,090 | 0 | 46,360 | 0 |
| End Cash Position | 0 | 25,990 | 0 | 24,380 | 0 |
| Net Cash Flow | $0 | $1,900 | $0 | $-21,980 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | 29,000 | 0 | 19,730 | 0 |
| Free Cash Flow | 0 | 29,000 | 0 | 19,730 | 0 |